ADLM Updates Emergency Department Drug Testing Guidance
New recommendations address evolving drug landscape and advancing testing technologies since original 2003 guidance.
New recommendations address evolving drug landscape and advancing testing technologies since original 2003 guidance.
Higher PVSA compliance rates lead to better clinical outcomes, enhancing the laboratory's reputation and value to healthcare providers.
Researchers developed a non-invasive cancer detection tool using nanowire-based miRNA extraction and AI to identify lung cancer in urine.
Sarstedt has been selected to exhibit its Needle-Free Transfer (NFT) Urine Collection System at the Vizient Innovative Technology Exchange.
Read MoreResearchers have developed a novel metasurface biosensor platform that improves the detection and monitoring of chronic kidney disease.
Read MoreLuxor Scientific has developed advanced testing solutions to address the nation’s ongoing overdose crises.
Read MoreThe CLP March/April 2024 Tech Guide in Clinical Lab Products (CLP) showcases a diverse array of products from seven laboratory providers.
Read MoreGeorge Mason University researchers have been awarded over $1 million to develop a urine-based Lyme disease test.
Read MoreA new study collected data on drug use by swabbing smartphone surfaces and analyzing residues. There are limitations to the method, however.
Read MoreResearchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Read MoreQuidelOrtho added the immunoassay for the qualitative detection of fentanyl to its Vitros systems to address the need for opioid testing.
Read MoreNanostics announced an agreement with Alberta Health Services to help drive diagnostic and prognostic innovations in urological care.
Read MoreThe new drug screening technique can rapidly detect the presence of 40 forensically relevant drugs from urine samples.
Read MoreTianeptine is often described as “gas-station dope” and products containing tianeptine commonly use the street names of “ZaZa” or “Tianna.”
Read MorePathogenDx’s UTI test is built on its D3 Array Platform. The multiplex test has a quick turnaround time with less waste.
Read MoreThe new panel from Quest tests for 88 compounds, and covers a broad array of drug classes, and other illicit additives.
Read MoreThis product design aims to transform workflows, expediting results for labs tasked to provide care for victims of drug-facilitated crimes.
Read MoreResearchers reported the enhanced performance of urinary biomarkers compared to plasma biomarkers for disease detection.
Read More